Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinolink Securities Co., Ltd., also known as Guojin Securities, is a leading full-service Chinese brokerage and investment banking firm headquartered in Chengdu. The company provides a comprehensive suite of financial services, including securities brokerage, investment consulting, asset management, and underwriting. While not a life sciences company itself, Sinolink is a significant player in the healthcare sector through its specialized equity research, venture capital investments, and advisory services for biotech and pharmaceutical IPOs in China. It is publicly traded on the Shanghai Stock Exchange and is recognized for its early adoption of internet-based financial services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinolink Securities.